About Surf Bio
Surf Bio is a company based in Palo Alto (United States) founded in 2021 by Bryan Mazlish was acquired by Halozyme in January 2026. Surf Bio has raised $16.02 million across 2 funding rounds from investors including Halozyme, Gates Foundation and Xontogeny. Surf Bio offers products and services including Surf SnapShot™. Surf Bio operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Sana Biotechnology and Cidara Therapeutics, among others.
- Headquarter Palo Alto, United States
- Founders Bryan Mazlish
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Surf Bio
Surf Bio offers a comprehensive portfolio of products and services, including Surf SnapShot™.
Enables high-concentration subcutaneous injections for biologics and antibodies.
People of Surf Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Surf Bio
Surf Bio has successfully raised a total of $16.02M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.6 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Surf Bio
Surf Bio has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Halozyme, Gates Foundation and Xontogeny.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in science-driven companies are made.
|
Locked | Locked | Locked | |
|
Life science startups are accelerated through focused programs by Xontogeny.
|
Locked | Locked | Locked | |
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked |
Investor details for Surf Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Surf Bio
Investment portfolio details for Surf Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Surf Bio
Detailed financials for Surf Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Surf Bio Comparisons
Peer comparison for Surf Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Surf Bio
Surf Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Sana Biotechnology and Cidara Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment
|
Detailed competitors of Surf Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Surf Bio
Complete news archive for Surf Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surf Bio
Surf Bio was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Surf Bio is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Bryan Mazlish is the current CEO of Surf Bio. They have also founded this company.
Surf Bio is a funded company, having raised a total of $16.02M across 2 funding rounds to date.
Founded in 2021 and based in Palo Alto, United States, therapeutics are developed by Surf Bio for diabetes, oncology, infectious diseases, gene therapy, and related areas. A biotechnology platform is utilized to create solutions, with the primary focus on ultra-rapid insulin for diabetes management. Operations center on advancing these programs through research and development in the biotech sector.
Surf Bio's top competitors include Vaxcyte, Sana Biotechnology and Semma Therapeutics.
Surf Bio offers Surf SnapShot™.
Surf Bio has 4 investors. Key investors include Halozyme, Gates Foundation, Xontogeny, and Breakout Ventures.